ENGENIOUS Trademark

Trademark Overview

On Monday, August 31, 2020, a trademark application was filed for ENGENIOUS with the United States Patent and Trademark Office. The USPTO has given the ENGENIOUS trademark a serial number of 90148530. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 14, 2024. This trademark is owned by Ensoma, Inc.. The ENGENIOUS trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for medical purposes, namely, vectors for delivering gene modification technologies into cells for the prevention and treatment of genetic diseases, infectious diseases, autoimmune diseases, diseases of oncology, hematology, immunodeficiency, and inborn errors of metabolism; chemical and diagnostic preparations in the nature of vectors for delivering gene modification technologies into cells for treatment of genetic diseases, infectious diseases, autoimmune diseases, diseases of oncology, hematology, immunodeficiency, and inborn errors of metabolism
engenious

General Information

Serial Number90148530
Word MarkENGENIOUS
Filing DateMonday, August 31, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 13, 2021

Trademark Statements

Goods and ServicesBiological preparations for medical purposes, namely, vectors for delivering gene modification technologies into cells for the prevention and treatment of genetic diseases, infectious diseases, autoimmune diseases, diseases of oncology, hematology, immunodeficiency, and inborn errors of metabolism; chemical and diagnostic preparations in the nature of vectors for delivering gene modification technologies into cells for treatment of genetic diseases, infectious diseases, autoimmune diseases, diseases of oncology, hematology, immunodeficiency, and inborn errors of metabolism

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 9, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEnsoma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameEnsoma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02111

Trademark Events

Event DateEvent Description
Thursday, September 3, 2020NEW APPLICATION ENTERED
Sunday, October 4, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 5, 2021ASSIGNED TO EXAMINER
Friday, May 28, 2021ASSIGNED TO EXAMINER
Monday, January 11, 2021NON-FINAL ACTION WRITTEN
Monday, January 11, 2021NON-FINAL ACTION E-MAILED
Monday, January 11, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 13, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 13, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 13, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 9, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 9, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 9, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, June 9, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, June 9, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 23, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 13, 2021PUBLISHED FOR OPPOSITION
Tuesday, September 7, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, September 7, 2021SOU EXTENSION 1 FILED
Tuesday, September 7, 2021SOU EXTENSION 1 GRANTED
Tuesday, September 7, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 23, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 23, 2022SOU EXTENSION 2 FILED
Tuesday, August 23, 2022SOU EXTENSION 2 GRANTED
Friday, July 7, 2023SOU EXTENSION 4 FILED
Wednesday, February 8, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, February 8, 2023SOU EXTENSION 3 FILED
Wednesday, February 8, 2023SOU EXTENSION 3 GRANTED
Friday, February 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 7, 2023SOU TEAS EXTENSION RECEIVED
Friday, July 7, 2023SOU EXTENSION 4 GRANTED
Tuesday, January 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 9, 2024SOU EXTENSION 5 FILED
Thursday, January 25, 2024SOU EXTENSION 5 GRANTED
Thursday, January 25, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 14, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, October 14, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Friday, January 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

engenious diseases oncology autoimmune infectious hematology immunodeficiency metabolism errors inborn genetic